These observations are in line with the previous studies reporting a rising percentage of deranged CD25+ FOXP3+ Tregs among CD4+ T cells in severe compared to mild COVID-19 patients which returned to normal levels only in the recovering individuals (4, 11–13, 46). This evidence concerns the gene CD4 and COVID-19.